News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Doogan Declan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4/A
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 2,464 shares
@ $67.8274, valued at
$167.1k
Sold 13,334 shares
@ $68.1523, valued at
$908.7k
Sold 15,508 shares
@ $68.5828, valued at
$1.1M
Sold 10,000 shares
@ $68.97, valued at
$689.7k
|
|
| 02/11/2022 |
4/A
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 11,706 shares
@ $64.4221, valued at
$754.1k
Sold 13,333 shares
@ $64.7077, valued at
$862.7k
Sold 12,580 shares
@ $65.5513, valued at
$824.6k
Sold 13,334 shares
@ $66.0053, valued at
$880.1k
|
|
| 12/01/2021 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 13,026 shares
@ $112.3996, valued at
$1.5M
Sold 11,499 shares
@ $113.2547, valued at
$1.3M
|
|
| 11/17/2021 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 12,437 shares
@ $115.9042, valued at
$1.4M
Sold 18,230 shares
@ $116.6853, valued at
$2.1M
Sold 7,073 shares
@ $117.8724, valued at
$833.7k
Exercised 250,000 options to buy
@ $0.61, valued at
$152.5k
Exercised 175,000 options to buy
@ $5.6, valued at
$980k
Exercised 50,000 options to buy
@ $9.29, valued at
$464.5k
Exercised 18,000 options to buy
@ $28.76, valued at
$517.7k
Exercised 18,000 options to buy
@ $61.76, valued at
$1.1M
Exercised 30,000 options to buy
@ $10.82, valued at
$324.6k
Exercised 18,000 options to buy
@ $47.1, valued at
$847.8k
|
|
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 11,164 shares
@ $65.6181, valued at
$732.6k
Sold 34,336 shares
@ $66.0494, valued at
$2.3M
Sold 18,703 shares
@ $67.5056, valued at
$1.3M
Sold 15,797 shares
@ $68.1016, valued at
$1.1M
Sold 2,572 shares
@ $66.9369, valued at
$172.2k
Sold 31,920 shares
@ $67.9046, valued at
$2.2M
Sold 25,208 shares
@ $68.7265, valued at
$1.7M
Sold 300 shares
@ $69.4167, valued at
$20.8k
|
|
| 06/12/2020 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 16,444 shares
@ $61.9672, valued at
$1M
Sold 20,043 shares
@ $62.7754, valued at
$1.3M
Sold 18,474 shares
@ $63.794, valued at
$1.2M
Sold 25,039 shares
@ $64.5742, valued at
$1.6M
Sold 7,600 shares
@ $62.9279, valued at
$478.3k
Sold 18,400 shares
@ $63.9004, valued at
$1.2M
Sold 28,086 shares
@ $64.7897, valued at
$1.8M
Sold 25,914 shares
@ $65.7849, valued at
$1.7M
|
|
| 05/01/2020 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Granted 18,000 options to buy
@ $47.1, valued at
$847.8k
|
|
| 05/23/2019 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Granted 18,000 options to buy
@ $61.76, valued at
$1.1M
|
|
| 04/16/2019 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 38,825 shares
@ $53.92, valued at
$2.1M
Sold 50,000 shares
@ $61.92, valued at
$3.1M
|
|
| 03/26/2019 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 5,351 shares
@ $53.66, valued at
$287.1k
Sold 5,824 shares
@ $53.72, valued at
$312.9k
|
|
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2018 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 40,000 shares
@ $41.95, valued at
$1.7M
|
|
| 06/06/2018 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 39,453 shares
@ $35.05, valued at
$1.4M
Sold 49,463 shares
@ $35.41, valued at
$1.8M
Sold 300 shares
@ $36, valued at
$10.8k
|
|
| 06/01/2018 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 842 shares
@ $35, valued at
$29.5k
Sold 26,044 shares
@ $35.01, valued at
$911.8k
Sold 83,898 shares
@ $35.04, valued at
$2.9M
|
|
| 05/03/2018 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Granted 18,000 options to buy
@ $28.76, valued at
$517.7k
|
|
| 01/18/2018 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 37,033 shares
@ $26.59, valued at
$984.7k
Sold 1,834 shares
@ $27.07, valued at
$49.6k
Sold 23,726 shares
@ $26.19, valued at
$621.4k
Sold 37,530 shares
@ $26.84, valued at
$1M
Sold 4,546 shares
@ $26.71, valued at
$121.4k
Sold 5,618 shares
@ $27.87, valued at
$156.6k
Sold 17,671 shares
@ $28.71, valued at
$507.3k
Sold 100 shares
@ $29.22, valued at
$2.9k
|
|
| 01/12/2018 |
4
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 23,869 shares
@ $27.13, valued at
$647.6k
Sold 13,793 shares
@ $28.34, valued at
$390.9k
Sold 2,600 shares
@ $29.31, valued at
$76.2k
Sold 100 shares
@ $29.98, valued at
$3k
Sold 46,746 shares
@ $26.27, valued at
$1.2M
Sold 1,392 shares
@ $26.77, valued at
$37.3k
Sold 13,599 shares
@ $26.19, valued at
$356.2k
Sold 19,843 shares
@ $26.53, valued at
$526.4k
|
|
| 05/03/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|